August 2014

Panel Discussion led by Seema Sonnad,PhD, that saw participation from ASCO's president Peter Paul Yu, MD; Jennifer Malin, MD, PhD, from WellPoint; Chadi Nabhan, MD, FACP, from the University of Chicago; and I.W. Tischler, MD, from Cigna.

ASCO's Initiative to Define Value In Cancer Care

ByRichard L. Schilsky, MD, Chief Medical Officer, ASCO

August 21st 2014

Commentary

August 2014

Robotic-Assisted Surgery: A Question of Value

FDA Moves to Regulate Thousands of Diagnostic Tests

In New Jersey, Focus in Fight Against Cancer Changes, and Care Comes Closer to Home

A Glimpse Into Managed Care of Diagnostics

A New Method to Fight Cancer: The Body's Own Immune System

Patient-Centered Physician Selection: A Necessary First Step for Accountable Care

Digital Technologies Gain Popularity for Smoking Cessation: Evidence Strongly Supports Some

Studies See Value of Prostate Cancer Diagnostic Test, but Will CMS Pay for It?

Reducing Risk and Improving Efficacy of Clinical Trials: the Adaptive Design

How Do You Establish Value in Cancer Care?

MMRF Efforts Attack the Disease From Every Angle; "Transformation" on the Horizon

AJMC Panel: Advances in Multiple Myeloma Therapy Extend Survival for Patients, Raising Cost Concerns

WellPoint Initiative May Challenge Some Practices

WellPoint Hopes a Name Change Will Ensure a New Tide of Consumers

AJMC Panel Asks: Does it Pay to Use Pathways?

ASCO's Initiative to Define Value In Cancer Care

Trending on AJMC

Government Shutdown Concluded but ACA Subsidies in Limbo

Can a Coffee a Day Keep AFib Away?

FDA Approves Ziftomenib for R/R NPM1-Mutated AML

High BMI Drives Worldwide Surge in Ovarian, Uterine Cancer Cases

How MS Treatment Strategies Are Evolving: Rebecca Spain, MD